GENMAB risk profile
46 Elevated one input has moved against it
Measured 1 September 2026 from GE9's filed statements. Recomputed nightly.
46 (Elevated), driven by Operating pressure at 68, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 34 | Normal | Stable | One-year price volatility — 33.3% |
| Operating pressure | 68 | Stretched | Worsening | Costs outgrowing revenue — +7.0 percentage points |
| Cash conversion | 22 | Normal | Easing | Cash conversion — 1.23x |
| Leverage and coverage | Reads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company. | |||
| Competitive position | 44 | Elevated | Stable | Revenue-growth gap against peers — -104.4 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.